230 related articles for article (PubMed ID: 7644246)
1. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron.
Schwörer H; Hartmann H; Ramadori G
Pain; 1995 Apr; 61(1):33-37. PubMed ID: 7644246
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cholestatic itching in primary biliary cirrhosis with ondansetron.
Di Martino M; Galanti B; Nardiello S
Ital J Gastroenterol; 1995; 27(8):455. PubMed ID: 8775475
[No Abstract] [Full Text] [Related]
3. The role of ondansetron in the management of cholestatic or uremic pruritus--a systematic review.
To TH; Clark K; Lam L; Shelby-James T; Currow DC
J Pain Symptom Manage; 2012 Nov; 44(5):725-30. PubMed ID: 22727254
[TBL] [Abstract][Full Text] [Related]
4. [Cholestatic pruritus--pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists].
Schwörer H; Ramadori G
Z Gastroenterol; 1995 May; 33(5):265-74. PubMed ID: 7610695
[TBL] [Abstract][Full Text] [Related]
5. A controlled trial of ondansetron in the pruritus of cholestasis.
O'Donohue JW; Pereira SP; Ashdown AC; Haigh CG; Wilkinson JR; Williams R
Aliment Pharmacol Ther; 2005 Apr; 21(8):1041-5. PubMed ID: 15813840
[TBL] [Abstract][Full Text] [Related]
6. [Ondansetron for cholestatic pruritus].
Lamelo Alfonsín F; Vila Arias M; San Martín Moreira J; Silva César M
An Med Interna; 1998 Aug; 15(8):456. PubMed ID: 9780438
[No Abstract] [Full Text] [Related]
7. Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.
Bolier R; de Vries ES; Parés A; Helder J; Kemper EM; Zwinderman K; Elferink RPO; Beuers U;
Trials; 2017 May; 18(1):230. PubMed ID: 28535810
[TBL] [Abstract][Full Text] [Related]
8. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.
de Vries E; Bolier R; Goet J; Parés A; Verbeek J; de Vree M; Drenth J; van Erpecum K; van Nieuwkerk K; van der Heide F; Mostafavi N; Helder J; Ponsioen C; Oude Elferink R; van Buuren H; Beuers U;
Gastroenterology; 2021 Feb; 160(3):734-743.e6. PubMed ID: 33031833
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
[TBL] [Abstract][Full Text] [Related]
10. Use of Butorphanol as Treatment for Cholestatic Itch.
Golpanian RS; Yosipovitch G; Levy C
Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
[TBL] [Abstract][Full Text] [Related]
11. Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists.
Schwörer H; Ramadori G
Clin Investig; 1993 Aug; 71(8):659-62. PubMed ID: 8219665
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial.
Müller C; Pongratz S; Pidlich J; Penner E; Kaider A; Schemper M; Raderer M; Scheithauer W; Ferenci P
Eur J Gastroenterol Hepatol; 1998 Oct; 10(10):865-70. PubMed ID: 9831410
[TBL] [Abstract][Full Text] [Related]
13. Ondansetron therapy for uremic pruritus in hemodialysis patients.
Ashmore SD; Jones CH; Newstead CG; Daly MJ; Chrystyn H
Am J Kidney Dis; 2000 May; 35(5):827-31. PubMed ID: 10793015
[TBL] [Abstract][Full Text] [Related]
14. Ondansetron for pruritus in child with chronic cholestasis.
Trioche P; Samuel D; Odièvre M; Labrune P
Eur J Pediatr; 1996 Nov; 155(11):990. PubMed ID: 8911904
[No Abstract] [Full Text] [Related]
15. 5HT3 receptor antagonists and pruritus due to cholestasis.
Quigley C
Palliat Med; 1996 Jan; 10(1):54. PubMed ID: 8821191
[No Abstract] [Full Text] [Related]
16. Plasma serotonin and histamine levels in hemodialysis-related pruritus are not significantly influenced by 5-HT3 receptor blocker and antihistaminic therapy.
Weisshaar E; Dunker N; Domröse U; Neumann KH; Gollnick H
Clin Nephrol; 2003 Feb; 59(2):124-9. PubMed ID: 12608555
[TBL] [Abstract][Full Text] [Related]
17. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.
Wolfhagen FH; Sternieri E; Hop WC; Vitale G; Bertolotti M; Van Buuren HR
Gastroenterology; 1997 Oct; 113(4):1264-9. PubMed ID: 9322521
[TBL] [Abstract][Full Text] [Related]
18. Improvement of cholestatic pruritus by ondansetron.
Schwörer H; Ramadori G
Lancet; 1993 May; 341(8855):1277. PubMed ID: 8098410
[No Abstract] [Full Text] [Related]
19. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.
Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A
Nephron; 1998; 78(4):395-402. PubMed ID: 9578065
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology and current management of pruritus in liver disease.
Kremer AE; Oude Elferink RP; Beuers U
Clin Res Hepatol Gastroenterol; 2011 Feb; 35(2):89-97. PubMed ID: 21809485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
